Data de apresentação do pedido
20 April 2006
Palavras-chave
Países de risco
Status atual
Rejected
Setor
NCP

Alegações

Ratiopharm, a pharmaceuticals company and major producer of generic drugs, has allegedly engaged in unethical marketing practices, including bribing doctors and pharmacists in Belgium, Canada, Spain, Estonia and Germany.

Orientações relevantes da OCDE

Resultado

In June 2006, the German NCP rejected the complaint citing the lack of transnational investment. Specifically, the NCP stated the complaint only dealt with alleged misbehaviour in Germany. In July 2006, Transparency International Germany resubmitted a revised and expanded complaint

Mais detalhes

Acusado
Empresa em situação de infração
Reclamantes
Pessoas afetadas
Data rejeitada / concluída
27 June 2006

Queixas relacionadas

Documentos

  • arquivo
    18 July 2006

    TI submits revised and expanded complaint (see: Transparency International - Germany vs. Ratiopharm refile).

    Transparency International Germany
  • arquivo
    20 April 2006

    Complaint submitted to German NCP.

    Transparency International Germany